Skip to content
Menu

Guggenheim Maintains Buy on CG Oncology, Raises Price Target to $120

Benzinga Newsdesk 15 hours ago

Analyst RatingsNewsPrice Target

This page contains a summary, not the full article. Continue to benzinga.com to read the original report.

Guggenheim analyst Michael Schmidt maintains CG Oncology (NASDAQ:CGON) with a Buy and raises the price target from $89 to $120.

Guggenheim analyst Michael Schmidt maintains CG Oncology (NASDAQ:CGON) with a Buy and raises the price target from $89 to $120.

Read at benzinga.com